John R. Pinion II

Chief Quality Officer and Executive Vice President, Translational Sciences at Ultragenyx Pharmaceutical Inc.

Are you John R. Pinion II? Claim your profile
 
  • IDENTIFY executive and board member connections in John R. Pinion II's network.
  • FOLLOW changes in John R. Pinion II's employment.
  • CONNECT with John R. Pinion II through your network of contacts.

John R. Pinion II's Executive Work History


Current
Chief Quality Officer and Executive Vice President, Translational Sciences, Ultragenyx Pharmaceutical Inc.
Past
To view John R. Pinion II's complete executive work history,
Age
52
 
 

John R. Pinion II's Biography


John R. Pinion II has served as our Chief Quality Officer and Executive Vice President of Translational Sciences since September 2017. Between January 2016 and September 2017, he served as our Executive Vice President of Analytical Sciences and Research, and between July 2015 and September 2017, as our Chief Quality Operations Officer. Between July 2015 and January 2016, he served as our Senior Vice President of Analytical Sciences and Research. Prior to Ultragenyx, Mr. Pinion served in various roles with increasing responsibilities at Genentech, a pharmaceutical company, between 2005 and June 2015, including his most recent position as the S ...

(Read More)

Source: Ultragenyx Pharmaceutical Inc. on 04/27/2018

 

By accessing BoardEdge, you can view bios, network, connections and references of industry leading executives like John R. Pinion II. More specifically, you'll be able to:

  • IDENTIFY executive and board member connections in John R. Pinion II's network.
  • FOLLOW changes in John R. Pinion II's employment.
  • CONNECT with John R. Pinion II through your network of contacts.
 

Access over 200,000 executive and board member profiles.

/bio

Example: John R. Pinion II

John R. Pinion II's Connections (17)


Chairman of the Board, Amarin Corporation plc
Dir., President and Chief Executive Officer, Ultragenyx Pharmaceutical Inc.
Chief Financial Officer and Executive Vice President, Ultragenyx Pharmaceutical Inc.
Chief Technical Operations Officer and Senior Vice President, Ultragenyx Pharmaceutical Inc.
President and Chief Executive Officer and Director, Aimmune Therapeutics, Inc.
President, Chief Executive Officer and Chairman of the Board, Seattle Genetics, Inc.